Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ovarian inflammatory and intracellular signaling pathways encompass a broad array of molecular networks that govern essential reproductive processes, including oocyte maturation, ovulation, and corpus luteum formation (Duffy et al., 2019, PMID: 30541137). These pathways, such as the NF-κB, PI3K/Akt/mTOR, and MAPK/ERK cascades, integrate signals from gonadotropins and local growth factors to maintain ovarian homeostasis. Chronic activation or dysregulation of these inflammatory signals is a hallmark of conditions like polycystic ovary syndrome (PCOS), where they contribute to insulin resistance and hyperandrogenism (Gonzalez, 2012, PMID: 22222341). In the context of oncology, aberrant signaling within these pathways drives the proliferation and survival of ovarian cancer cells (Ghoneum et al., 2020, PMID: 32824581). Because this term describes a collection of processes rather than a single protein, it is not considered a discrete therapeutic target, though many of its constituent molecules are targeted by specific drugs.
Modulation of intracellular cascades such as PI3K/Akt, MAPK, and NF-κB to regulate follicular growth, steroidogenesis, and inflammatory cytokine production.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ovarian inflammatory and intracellular signaling pathways.